The results of this study are consistent with effects observed in clinical trials in obese patients, said Penny Ward, an independent pharmaceutical physician and visiting professor in pharmaceutical medicine at King's College London in the U.K
"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial." The Lancet , 402(10404), 529-544
Development 146:166074
Clinical observations have demonstrated that plasma betaine levels in patients with cirrhosis are associated with disease severity and decrease after liver transplantation, indicating their association with disease progression (137)
With IV B12, the vitamin goes straight into the blood, skipping the digestive system